Biocytogen Pharmaceuticals (SSE: 688796; HKEX: 02315) announced that partner IDEAYA Biosciences (NASDAQ: IDYA) has dosed the first patient in a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE